Detalhe da pesquisa
1.
Reassessing potential economic value and health impact of effective Shigella vaccines.
Bull World Health Organ
; 102(1): 65-74, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164339
2.
Understanding supplement use: an application of temporal self-regulation theory.
Psychol Health Med
; 23(2): 178-188, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28609120
3.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Vaccine
; 42(7): 1445-1453, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036392
4.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
Vaccine
; 42(7): 1454-1460, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030421
5.
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.
Vaccine
; 41(16): 2634-2644, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932030
6.
Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants.
Vaccine
; 33(8): 946-53, 2015 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500172
7.
Inflammatory disease of the aorta: patterns and classification of giant cell aortitis, Takayasu arteritis, and nonsyndromic aortitis.
J Thorac Cardiovasc Surg
; 149(2 Suppl): S170-5, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25218529